Related Experiment Videos
Hemostatic abnormalities may predict chronic hypertension after preeclampsia
1Department of Woman and Child Health, Karolinska Hospital, Stockholm, Sweden.
Gynecologic and Obstetric Investigation
|January 1, 1996
Summary
Women with severe preeclampsia show higher levels of blood clotting factors and thrombin activity markers post-delivery. These hemostatic changes may indicate an increased risk for future cardiovascular events.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Medicine
- Hematology
Background:
- Preeclampsia is a pregnancy-induced hypertensive disorder.
- Approximately 25-30% of women with preeclampsia develop essential hypertension later in life.
Purpose of the Study:
- To investigate hemostatic variables in women with a history of preeclampsia.
- To assess potential links between preeclampsia severity and long-term cardiovascular risk markers.
Main Methods:
- Studied 28 women with severe preeclampsia and 14 with mild preeclampsia 6-15 months postpartum.
- Measured various hemostatic variables, including coagulation inhibitors, prothrombin complex, fibrinogen, plasminogen activator inhibitor-1, and markers of thrombin activity.
Main Results:
- Elevated levels of protein C and total protein S were observed in severe preeclampsia cases.
- Increased prothrombin complex, fibrinogen, and plasminogen activator inhibitor-1 were noted in women with prior severe preeclampsia.
- Higher markers of thrombin activity (thrombin-antithrombin complex, prothrombin fragments 1+2, fibrin D-dimers, soluble fibrin) were found in the severe preeclampsia group.
- Factor VII antigen was elevated in women with a history of preeclampsia compared to controls.
Conclusions:
- Women with prior severe preeclampsia exhibit elevated coagulation factors and fibrinolytic inhibitor levels.
- Increased thrombin markers in these women suggest a prothrombotic state.
- These hemostatic alterations may predict future cardiovascular complications.